Moneycontrol PRO

business

Margins to scale up to 20% by FY15-end: Dishman Pharma

The company is now concentrating on high margins and high value business and expects a sizable improvement by the end of the year.

first published: Sep 12, 2014 03:15 pm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347